Unknown

Dataset Information

A cost effectiveness analysis of a quality improvement intervention to increase preferential balanced fluid prescribing.


ABSTRACT:

Background

The higher cost of balanced fluids has historically contributed to preferential normal saline (NS) use. Recent clinical trials demonstrated that balanced fluids reduced the incidence of major adverse kidney events among hospitalized patients and also reduced mortality among critically ill patients. This study sought to conduct an economic evaluation of a recently published quality improvement (QI) intervention to increase preferential balanced fluid prescribing, which significantly increased the relative proportion of balanced fluid orders.

Methods

Using clinical trial data and real-world data from our prior QI intervention in conjunction with local and regional cost data, we constructed a decision tree to examine the economic cost and clinical consequences of usi

SUBMITTER: Spiegel MC 

PROVIDER: S-EPMC11603869 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature